An NCAA committee has made a formal recommendation to remove cannabis from their banned substances list for college athletes.
In a recent press statement (1), the National Collegiate Athletic Association (NCAA) Committee on Competitive Safeguards and Medical Aspects of Sports (CSMAS) formally announced their recommendation that cannabis should be removed from the organization’s banned substances list for college athletes. The committee also stated (10 that all three of the organization’s governing bodies should “introduce and adopt legislation that would remove cannabinoids from the list of NCAA banned drug classes.”
This recommendation reportedly comes after an extensive study informed by industry and subject matter experts. In December 2022, the NCAA also hosted a Summit on Cannabinoids in College Athletics (2). The consensus opinion formed at that event was that cannabis was not a performance-enhancing drug and that a harm-reduction approach to cannabis would be best implemented at the school level.
The NCAA statement reads (1): “In short, removing cannabinoids from the list of banned substances:
"When making a decision on an important topic like this, we agree that the membership should have an opportunity to vote on the final outcome," said James Houle, committee chair and lead sport psychologist at Ohio State (1). "We are recommending a big shift in the paradigm when it comes to cannabinoids. We want to modernize the strategy with the most up-to-date research to give schools the best opportunity to support the health of student-athletes."
The exact timing of discussion and adoption of possible legislation is a decision that will be made by each of three NCAA divisional governance structures (1).
References
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.